{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:05:08Z","timestamp":1758845108508,"version":"3.44.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.pbb.2013.09.016","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T03:04:06Z","timestamp":1381201446000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: Effect of MDMA, DOI and 8-OH-DPAT"],"prefix":"10.1016","volume":"112","author":[{"given":"Shane J.","family":"Thwaites","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gogos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Van den Buuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2013.09.016_bb0010","first-page":"639","article-title":"Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia","volume":"17","author":"Adler","year":"1982","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0006-3223(86)90244-1","article-title":"Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol","volume":"21","author":"Adler","year":"1986","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0006-3223(88)90273-9","article-title":"Modulation of the gating of auditory evoked potentials by norepinephrine: pharmacological evidence obtained using a selective neurotoxin","volume":"24","author":"Adler","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0005","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1176\/ajp.161.10.1822","article-title":"Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients","volume":"161","author":"Adler","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clinph.2003.09.018","article-title":"Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia","volume":"115","author":"Becker","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.pbb.2013.09.016_bb0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-3223(90)90648-L","article-title":"Auditory sensory gating in hippocampal neurons: a model system in the rat","volume":"27","author":"Bickford-Wimer","year":"1990","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0165-1781(91)90086-5","article-title":"Test\u2013retest reliability of the P50 midlatency auditory evoked-response","volume":"39","author":"Boutros","year":"1991","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pbb.2013.09.016_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/155005949102200109","article-title":"Replication and extension of P50 findings in schizophrenia","volume":"22","author":"Boutros","year":"1991","journal-title":"Clin Electroencephalogr"},{"key":"10.1016\/j.pbb.2013.09.016_bb0035","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0006-3223(97)00161-3","article-title":"A parametric study of the N40 auditory evoked response in rats","volume":"42","author":"Boutros","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0040","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.schres.2009.05.019","article-title":"Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients","volume":"113","author":"Boutros","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2013.09.016_bb0055","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.biopsych.2006.08.015","article-title":"Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients","volume":"61","author":"Braff","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0920-9964(94)00043-8","article-title":"Serotonin, schizophrenia and antipsychotic drug action","volume":"14","author":"Breier","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2013.09.016_bb0065","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbr.2009.12.037","article-title":"Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats","volume":"208","author":"Breier","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2013.09.016_bb0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1469-8986.2004.00206.x","article-title":"P50 and acoustic startle gating are not related in healthy participants","volume":"41","author":"Brenner","year":"2004","journal-title":"Psychophysiology"},{"key":"10.1016\/j.pbb.2013.09.016_bb0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00008877-200503000-00009","article-title":"Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA)","volume":"16","author":"Bubenikova","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.016_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/ajp.157.1.55","article-title":"Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder","volume":"157","author":"Cadenhead","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0085","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.biopsych.2005.03.003","article-title":"P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment","volume":"57","author":"Cadenhead","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0090","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1469-8986.2010.01168.x","article-title":"Probing the relative contribution of the first and second responses to sensory gating indices: a meta-analysis","volume":"48","author":"Chang","year":"2011","journal-title":"Psychophysiology"},{"key":"10.1016\/j.pbb.2013.09.016_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pbb.2013.09.016_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","article-title":"EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis","volume":"134","author":"Delorme","year":"2004","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pbb.2013.09.016_bb0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(90)94150-V","article-title":"Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices","volume":"191","author":"Fitzgerald","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.016_bb0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2013.09.016_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00634450","article-title":"A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA","volume":"99","author":"Gold","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.09.016_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0010-440X(62)80024-8","article-title":"Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures","volume":"3","author":"Hollister","year":"1962","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00213-007-0921-x","article-title":"5-HT2A receptor density is decreased in the at-risk mental state","volume":"195","author":"Hurlemann","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.09.016_bb0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0022-3565(24)37468-3","article-title":"5-Hydroxytryptamine2 receptors modulate auditory filtering in the rat","volume":"285","author":"Johnson","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.09.016_bb0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-003-1731-4","article-title":"Effects of acute and chronic clozapine on D-amphetamine-induced disruption of auditory gating in the rat","volume":"174","author":"Joy","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.09.016_bb0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00213-006-0608-8","article-title":"Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential","volume":"190","author":"Keedy","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.09.016_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0028-3908(90)90047-U","article-title":"Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT","volume":"29","author":"Larsson","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.09.016_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11920-999-0008-y","article-title":"Human and animal studies of schizophrenia-related gating deficits","volume":"1","author":"Light","year":"1999","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pbb.2013.09.016_bb0160","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0006-3223(99)00034-7","article-title":"Amphetamine disrupts P50 suppression in normal subjects","volume":"46","author":"Light","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1176\/appi.ajp.157.5.767","article-title":"Normal P50 suppression in schizophrenia treated with atypical antipsychotic medications","volume":"157","author":"Light","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0006-8993(92)91437-J","article-title":"Cholinergic gating of response to auditory stimuli in rat hippocampus","volume":"587","author":"Luntzleybman","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.09.016_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-011-2274-8","article-title":"GABA(B) receptor blockade in the hippocampus affects sensory and sensorimotor gating in Long-Evans rats","volume":"217","author":"Ma","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.09.016_bb0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.09.016_bb0180","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/npp.2011.163","article-title":"Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population","volume":"36","author":"Moses-Kolko","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.016_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-3223(95)00371-1","article-title":"Gating of auditory P50 in schizophrenics: unique effects of clozapine","volume":"40","author":"Nagamoto","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0190","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1176\/appi.ajp.157.6.1016","article-title":"Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: a PET study using [F-18]setoperone","volume":"157","author":"Ngan","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.016_bb0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2010.03.004","article-title":"Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia","volume":"119","author":"Olincy","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2013.09.016_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psychres.2007.02.009","article-title":"P50 sensory gating ratios in schizophrenics and controls: a review and data analysis","volume":"158","author":"Patterson","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pbb.2013.09.016_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02246157","article-title":"Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats","volume":"119","author":"Stevens","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.09.016_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00726-006-0374-2","article-title":"The 5-HT1A receptor active compounds (R)-8-OH-DPAT and (S)-UH-301 modulate auditory evoked EEG responses in rats","volume":"31","author":"Stevens","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.pbb.2013.09.016_bb0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1566-2772(03)00017-3","article-title":"Preclinical effects of conventional and atypical antipsychotic drugs: defining the mechanisms of action","volume":"3","author":"Svensson","year":"2003","journal-title":"Clin Neurosci Res"},{"key":"10.1016\/j.pbb.2013.09.016_bb0220","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.npp.1300841","article-title":"Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats","volume":"31","author":"Swerdlow","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.016_bb0225","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1017\/S1461145711000101","article-title":"Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT1A receptor knockout mice","volume":"14","author":"van den Buuse","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2013.09.016_bb0230","first-page":"1","article-title":"Input dysfunction in schizophrenia","volume":"72","author":"Venables","year":"1964","journal-title":"Prog Exp Pers Res"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713002323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713002323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:33:04Z","timestamp":1758774784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305713002323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":46,"alternative-id":["S0091305713002323"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.09.016","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: Effect of MDMA, DOI and 8-OH-DPAT","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2013.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}